Cited by 41Dementia and Cognitive Impairment ResearchContext-Aware Activity Recognition SystemsNon-Invasive Vital Sign Monitoring

Feasibility of Using a Wearable Biosensor Device in Patients at Risk for Alzheimer's Disease Dementia

Open access
Saif, N., Yan, P., Niotis, K., Scheyer, O., Rahman, A., Berkowitz, M., Krikorian, R., Hristov, H. +3 more·2020·The Journal of Prevention of Alzheimer's Disease

Abstract

BACKGROUND: Alzheimer's disease (AD) is the most common and most costly chronic neurodegenerative disease globally. AD develops over an extended period prior to cognitive symptoms, leaving a "window of opportunity" for targeted risk-reduction interventions. Further, this pre-dementia phase includes early physiological changes in sleep and autonomic regulation, for which wearable biosensor devices may offer a convenient and cost-effective method to assess AD-risk. METHODS: Patients with a family history of AD and no or minimal cognitive complaints were recruited from the Alzheimer's Prevention Clinic at Weill Cornell Medicine and New York-Presbyterian. Of the 40 consecutive patients screened, 34 (85%) agreed to wear a wearable biosensor device (WHOOP). One subject (2.5%) lost the device prior to data collection. Of the remaining subjects, 24 were classified as normal cognition and were asymptomatic, 6 were classified as subjective cognitive decline, and 3 were amyloid-positive (one with pre-clinical AD, one with pre-clinical Lewy-Body Dementia, and one with mild cognitive impairment due to AD). Sleep-cycle, autonomic (heart rate variability [HRV]) and activity measures were collected via WHOOP. Blood biomarkers and neuropsychological testing sensitive to cognitive changes in pre-clinical AD were obtained. Participants completed surveys assessing their sleep-patterns, exercise habits, and attitudes towards WHOOP. The goal of this prospective observational study was to determine the feasibility of using a wrist-worn biosensor device in patients at-risk for AD dementia. Unsupervised machine learning was performed to first separate participants into distinct phenotypic groups using the multivariate biometric data. Additional statistical analyses were conducted to examine correlations between individual biometric measures and cognitive performance. RESULTS: 27 (81.8%) participants completed the follow-up surveys. Twenty-four participants (88.9%) were satisfied with WHOOP after six months, and twenty-three (85.2%) wanted to continue wearing WHOOP. K-means clustering separated participants into two groups. Group 1 was older, had lower HRV, and spent more time in slow-wave sleep (SWS) than Group 2. Group 1 performed better on two cognitive tests assessing executive function: Flanker Inhibitory Attention/Control (FIAC) (p=.031), and Dimensional Change Card Sort (DCCS) (p=.061). In Group 1, DCCS was correlated with SWS (ρ=.68, p=0.024) and HRV (ρ=.6, p=0.019). In Group 2, DCCS was correlated with HRV (ρ=.55, p=0.018). There were no significant differences in blood biomarkers between the two groups. CONCLUSIONS: Wearable biosensor devices may be a feasible tool to assess AD-related physiological changes. Longitudinal collection of sleep and HRV data may potentially be a non-invasive method for monitoring cognitive changes related to pre-clinical AD. Further study is warranted in larger populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14283/jpad.2019.39

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In some studies (15/189, 7.9%), wearable prices were not transparent.

    “In some studies (15/189, 7.9%), wearable prices were not transparent, as data were provided through a variety of participant-owned wearables [87] or the wearable hardware was part of a subscription or a membership fee, that is, Whoop strap of Whoop [178].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Saif, N., Yan, P., Niotis, K., Scheyer, O., Rahman, A., Berkowitz, M., Krikorian, R., Hristov, H., Sadek, G., Bellara, S., & Isaacson, R. S.
Affiliations
  • Weill Cornell Medicine (US)
  • Beth Israel Deaconess Medical Center (US)
  • University of California, Los Angeles (US)
  • University of Cincinnati (US)
Corresponding author
Isaacson, Richard S.
Venue
The Journal of Prevention of Alzheimer's Disease
Publisher
Elsevier BV
Published
2020-03
Volume
7
Issue
2
Pages
104-111
ISSN
2274-5807 (ISSN-L)
OpenAlex
W2979675636
Cited by
41
References
40
Citations by year
2026: 4 · 2025: 5 · 2024: 13 · 2023: 8 · 2022: 7 · 2021: 3 · 2020: 1
FWCI
3.46
Type
journal article
Language
en
Open access
Locations
  • The Journal of Prevention of Alzheimer s Disease (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR002384)
  • National Institute on Aging (P01AG026572)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
  • Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
Keywords
Alzheimer's disease, preclinical Alzheimer's disease, wearable biosensors, WHOOP, heart rate variability, slow-wave sleep, autonomic regulation, subjective cognitive decline, family history of Alzheimer's disease, executive function, blood biomarkers, amyloid, dementia with Lewy bodies, mild cognitive impairment, device feasibility, K-means clustering, risk mitigation
MeSH terms
Wearable Electronic Devices, Adult, Aged, Alzheimer Disease, Feasibility Studies, Female, Heart Rate, Humans, Male, Middle Aged, Surveys and Questionnaires, Sleep, Risk Assessment, Actigraphy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review